QUALITY OF LIFE OF CHILDREN UNDER 4 YEARS OLD AND THEIR PARENTS AT THE NATIONAL CHILDREN’S HOSPITAL

Thị Kim Dung Khương1, Thị Diệu Thúy Nguyễn2,
1 Quang Ninh Provincial General Hospital
2 HMU

Main Article Content

Abstract

AtopiC dermatitis (AD) is not a life-threatening disease, but it remarkble affeCts the liVes of Children and their CaregiVers. The study was ConduCted to inVestigate the quality of life of Children under 4 years old with AD and CaregiVers at the National Children's Hospital in 2022 – 2023. Methods: There was a desCriptiVe Cross – seCtional study in ninety six Children less than 4 years old with AD and their CaregiVers. The questionnaires inCluded IDQoL, DFI, SCORAD were administrated to assess the quality of life of Children and CaregiVers and the seVerity of AD. Results: The mean oVerall sCores were 10.0 ± 5.5 for IDQoL and 9.8 ±7.0 for DFI. The highest sCore for IDQOL referred tO “itching and scratching”, “child’s mOOd” and “time tO get tO sleep”. FOr DFI the highest impacted dOmains were “tiredness/exhausted”, “expenditure” and “sleep fOr Others in familly”. There


was a signifiCant differenCe in mean sCore between IDQoL and DFI aCCording to the seVerity of AD. Conclusions: AD has a signifiCant negatiVe impaCt on quality of life of Children and their CaregiVers. The quality of life depends on the AD seVerity

Article Details

References

1. Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of Care for the manegement of atopiC dermatitis. J Am ACad Dermatol. 2014;70(2):338- 351. doi:10.1016/j.jaad.2013.10.010
2. Phạm Thu Hiền. Đặc điểm dịCh tễ họC eCzema ở trẻ dưới 5 tuổi tại Hà Nội, Hải Phòng Và thành phố Hồ Chí Minh năm 2014. Y tế Cộng đồng. 2018;Số 3(64):137-141.
3. Laughter M , Maymone M, Mashayekhi S, et al. The global burden of atopiC dermatitis: lessons from the Global Burden of Disease Study 1990– 2017*. British Journal of Dermatology. 2021;184(2):304-309. doi:10.1111/bjd.19580
4. Harmonising Outcome Measures for Eczema (HOME). Report from the First International Consensus Meeting (HOME 1), 24 July 2010, MuniCh, Germany - PubMed. ACCessed April 27, 2022. https://pubmed.nCbi.nlm.nih.goV/21137114/
5. Williams HC, Schmitt J, Thomas KS, et al. The HOME Core outCome set for CliniCal trials of atopiC dermatitis. J Allergy Clin Immunol. 2022; 149(6):1899-1911. doi:10.1016/j.jaCi.2022.03.017
6. Alvarenga TMM, Caldeira AP. Quality of life in pediatriC patients with atopiC dermatitis. J Pediatr (Rio J). 2009;85(5):415-420. doi:10.2223/JPED.1924
7. Monti F, Agostini F, Gobbi F, Neri E, Schianchi S, Arcangeli F. Quality of life measures in Italian Children with atopiC dermatitis and their families. Ital J Pediatr. 2011;37:59. doi:10.1186/1824-7288-37-59
8. Xu X, van Galen LS, Koh MJA, et al. FaCtors influenCing quality of life in Children with atopiC dermatitis and their CaregiVers: a Cross-seCtional study. SCi Rep. 2019;9(1):15990. doi:10.1038/s41598-019-51129-5